Investors Can Find Comfort In Fleury's (BVMF:FLRY3) Earnings Quality
Nov 16
Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Healthcare Services Industry Analysis
UpdatedNov 14, 2025
DataAggregated Company Financials
Companies11
- 7D-6.7%
- 3M6.6%
- 1Y20.0%
- YTD43.9%
Over the last 7 days, the Healthcare Services industry has dropped 6.7%, driven by a pullback from Hapvida Participações e Investimentos of 43%. On the other hand Diagnósticos da América is actually up 11%. In the past year, the industry has gained 20%. Earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the Brazilian Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 18 Nov 2025 | R$143.7b | R$141.9b | R$2.1b | 16.6x | 68.2x | 1x |
| Thu, 16 Oct 2025 | R$128.8b | R$140.1b | R$1.4b | 13.2x | 93.6x | 0.9x |
| Sat, 13 Sep 2025 | R$129.8b | R$140.1b | R$1.4b | 13.4x | 94.3x | 0.9x |
| Mon, 11 Aug 2025 | R$121.5b | R$141.6b | R$897.5m | 12.9x | 135.4x | 0.9x |
| Wed, 09 Jul 2025 | R$116.0b | R$139.7b | R$877.7m | 11.2x | 132.1x | 0.8x |
| Fri, 06 Jun 2025 | R$102.3b | R$110.2b | R$1.6b | 11.3x | 65.7x | 0.9x |
| Sun, 04 May 2025 | R$111.3b | R$137.9b | R$740.0m | 11.4x | 150.4x | 0.8x |
| Tue, 01 Apr 2025 | R$101.0b | R$140.2b | R$2.0b | 10.6x | 50.4x | 0.7x |
| Thu, 27 Feb 2025 | R$102.7b | R$136.0b | R$2.9b | 11x | 35.7x | 0.8x |
| Sat, 25 Jan 2025 | R$99.0b | R$136.0b | R$2.9b | 10.9x | 34.4x | 0.7x |
| Mon, 23 Dec 2024 | R$98.7b | R$136.0b | R$2.9b | 11.2x | 34.3x | 0.7x |
| Wed, 20 Nov 2024 | R$111.0b | R$137.4b | R$3.4b | 15.1x | 32.5x | 0.8x |
| Fri, 18 Oct 2024 | R$120.1b | R$134.1b | R$2.5b | 12.3x | 48x | 0.9x |
| Sun, 15 Sep 2024 | R$140.4b | R$134.1b | R$2.5b | 13.8x | 56.1x | 1x |
| Tue, 13 Aug 2024 | R$125.5b | R$132.3b | R$1.8b | 13.3x | 70.5x | 0.9x |
| Thu, 11 Jul 2024 | R$122.9b | R$132.2b | R$2.4b | 14.2x | 52.3x | 0.9x |
| Sat, 08 Jun 2024 | R$118.3b | R$132.2b | R$2.4b | 14.2x | 50.3x | 0.9x |
| Mon, 06 May 2024 | R$118.4b | R$129.5b | R$1.4b | 16.5x | 84.9x | 0.9x |
| Wed, 03 Apr 2024 | R$115.9b | R$129.5b | R$1.4b | 17.9x | 83.2x | 0.9x |
| Fri, 01 Mar 2024 | R$119.5b | R$122.1b | R$783.4m | 22.4x | 152.6x | 1x |
| Sun, 28 Jan 2024 | R$131.4b | R$124.2b | R$902.0m | 23.2x | 145.7x | 1.1x |
| Tue, 26 Dec 2023 | R$140.8b | R$124.2b | R$902.0m | 27.5x | 156.1x | 1.1x |
| Thu, 23 Nov 2023 | R$134.4b | R$124.2b | R$903.5m | 23.8x | 148.8x | 1.1x |
| Sat, 21 Oct 2023 | R$120.5b | R$115.3b | R$753.8m | 23.1x | 159.8x | 1x |
| Mon, 18 Sep 2023 | R$141.8b | R$115.3b | R$753.8m | 25.6x | 188.2x | 1.2x |
| Wed, 16 Aug 2023 | R$152.3b | R$114.3b | R$692.3m | 27.5x | 220x | 1.3x |
| Fri, 14 Jul 2023 | R$151.2b | R$106.3b | R$737.3m | 31.4x | 205.1x | 1.4x |
| Sun, 11 Jun 2023 | R$145.8b | R$106.3b | R$748.7m | 27.7x | 194.8x | 1.4x |
| Tue, 09 May 2023 | R$111.1b | R$96.2b | R$1.2b | 17.9x | 93x | 1.2x |
| Thu, 06 Apr 2023 | R$99.5b | R$96.0b | R$1.2b | 16.9x | 82.1x | 1x |
| Sat, 04 Mar 2023 | R$105.6b | R$92.5b | R$1.7b | 14.3x | 63.1x | 1.1x |
| Mon, 30 Jan 2023 | R$139.0b | R$88.6b | R$2.2b | 15.2x | 63.7x | 1.6x |
| Wed, 28 Dec 2022 | R$131.3b | R$88.6b | R$2.2b | 15.9x | 60.2x | 1.5x |
| Fri, 25 Nov 2022 | R$133.7b | R$88.6b | R$2.2b | 16.2x | 61.3x | 1.5x |
Price to Earnings Ratio
61.3x
Current Industry PE
- Investors are pessimistic on the Brazilian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 68.2x which is lower than its 3-year average PE of 102x.
- The industry is trading close to its 3-year average PS ratio of 1.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Brazilian Healthcare industry?
| BR Market | 0.86% | |
| Healthcare | -5.60% | |
| Healthcare Services | -6.69% | |
| Healthcare Distributors | 6.10% | |
| Healthcare Services | 3.45% | |
| Healthcare Facilities | -3.09% | |
| Managed Healthcare | -30.12% | |
Industry PE
- Investors are most optimistic about the Managed Healthcare industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 35.0%, which is higher than its past year's earnings growth of 6.6% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Distributors industry, expecting annual earnings growth of 131% over the next 5 years.
- This is better than its past earnings growth rate of 7.7% per year.
- In contrast, the Healthcare Facilities industry is expected to see its earnings grow by 17% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DASA3 Diagnósticos da América | R$2.25 | 11.4% +R$287.4m | 3.2% | PS0.2x | |
| ONCO3 Oncoclínicas do Brasil Serviços Médicos | R$2.07 | 15.0% +R$171.1m | -43.4% | PS0.2x | |
| VVEO3 CM Hospitalar S/A | R$1.57 | 19.8% +R$82.1m | -21.1% | PS0.04x | |
| MATD3 Hospital Mater Dei | R$4.52 | 4.1% +R$59.4m | 4.9% | PE18.4x | |
| PFRM3 Profarma Distribuidora de Produtos Farmacêuticos | R$8.26 | 0.7% +R$7.4m | 18.2% | PE8.8x |
